Worldwide Autoimmune Disease Diagnostics Industry to 2026 - Increasing Epidemiology of Autoimmune Diseases is Driving Growth -

DUBLIN--()--The "Autoimmune Disease Diagnostics: Global Markets 2021-2026" report has been added to's offering.

The global market for autoimmune disease diagnostics should grow from $13.7 billion in 2021 to $17.0 billion by 2026, at a compound annual growth rate (CAGR) of 4.4% for the period of 2021-2026.

Companies Mentioned

  • Abbott
  • BD Biosciences
  • Beckman Coulter Inc.
  • Bio-Rad (Abd Serotec)
  • Biomerieux
  • Bristol-Myers Squibb
  • Euroimmun (PerkinElmer)
  • F. Hoffmann-La Roche Ag
  • Siemens Healthcare
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Group (Immco Diagnostics)

The report will provide details about autoimmune disease diagnostics used in the treatment of autoimmune disease and how the market has been influenced by the pandemic of COVID-19. This report will also highlight the current and future market potential of autoimmune disease diagnostics with detailed analyses of the competitive environments between companies. Drivers, restraints, opportunities, pricing analysis, prevalence or incidence of autoimmune disease and regulatory scenarios will also be covered. The report includes a market projection for 2026 and market shares for key players.

The report segments the market for autoimmune disease diagnostics based on technology, gender, indications and geography. Based on technology, the market is segmented into indirect immunofluorescence (IIF), enzyme-linked immunosorbent assay (ELISA), ImmunoBlot, multiplex immunoassays and others. Based on indications, the market is segmented into type 1 diabetes, rheumatoid arthritis (RA), psoriasis/psoriatic arthritis, multiple sclerosis, inflammatory bowel disease, systemic lupus erythematosus (SLE), and others (pernicious anemia, celiac disease, autoimmune vasculitis, myasthenia gravis, Hashimoto's thyroiditis, Sjogren's syndrome, Graves' disease, Addison's disease, etc.). Based on gender, the market is segmented into males and females.

By geography, the market has been segmented into North America, Europe, the Asia-Pacific and the Rest of the World. A detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, the Gulf Cooperation Council countries and South Africa will be covered in the regional segments. For market estimates, data will be provided for 2020 as the base year, with estimates for 2021 and forecast values for 2026.

Report Includes

  • 37 data tables and 33 additional tables
  • An overview of the global market for autoimmune disease diagnostics
  • Estimation of the market size and analyses of the global market trends, with data from 2019, 2020 estimates for 2021 with a projection of CAGR through 2026
  • Market share analysis of autoimmune disease diagnostics based on technology, indication, region and gender and identification of new opportunities, challenges, and technological changes within the industry
  • A detailed description of autoimmune disorder & therapies, and causes such as intrinsic factors, environmental factors, and lifestyle factors, and insights into a new diagnostic pathway for autoimmune and inflammatory disorders
  • Discussion on the role of bioinformatics and biomarkers on autoimmune disorder therapies and information on standardization of test results
  • Coverage of new product launches in the therapeutics for autoimmune diseases and performance methods in the detection of autoimmune antibodies
  • Detailed analysis of the current market trends, market forecast, and discussion of technological, and regulatory elements that are affecting the future marketplace

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

  • Report Highlights

Chapter 3 Market and Technology Background

  • Autoimmune Disorders and Therapies
  • Causes of Autoimmune Diseases
  • Intrinsic Factors
  • Environmental Factors
  • Lifestyle Factors
  • Key Challenges in the Industry
  • Standardization of Test Results
  • Lack of Awareness Among Patients of Autoimmune Complications
  • Shortage of Skilled Technicians for Performing Diagnostic Assays
  • Emerging Technologies in Autoimmune Diagnostics
  • Bioinformatics
  • Biomarkers
  • Applications for Mobile Phones
  • Lab Automation

Chapter 4 Market Dynamics

  • Market Drivers
  • Increasing Epidemiology of Autoimmune Diseases
  • Rise in the Geriatric Population
  • Rising Awareness of Autoimmune Diseases
  • New Diagnostic Pathway for Autoimmune and Inflammatory Disorders
  • Market Restraints
  • Low Availability of Diagnosis Kits in Laboratories
  • High Cost of Autoimmune Disease Diagnostics
  • Market Opportunities
  • Launch of New Therapeutics for Autoimmune Diseases
  • Growing Rate of Autoimmunity in Population

Chapter 5 Market Breakdown by Gender

Chapter 6 Market Breakdown by Technology

Chapter 7 Market Breakdown by Indication

Chapter 8 Market Breakdown by Region

Chapter 9 Impact of COVID-19 on Autoimmune Disease Diagnostics Market

  • Autoimmune Disease and COVID-19 Treatment
  • Complexities of Diagnosis and Management of COVID-19 in Autoimmune Diseases

Chapter 10 Value Chain Analysis

  • Demand Chain Analysis
  • Customers (Patients)
  • Payers
  • Supply Chain Analysis
  • Laboratories
  • Manufacturers

Chapter 11 Regulatory Scenario

  • European Regulations
  • North American Regulations
  • U.S. Regulations
  • Canadian Regulations
  • Latin American Regulations
  • Asia-Pacific Regulations
  • Future Regulatory Trends

Chapter 12 Competitive Landscape

Chapter 13 Company Profiles

Chapter 14 Appendix: Acronyms

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900